According to clinicaltrials.gov, the number of clinical trial studies in the Asian region has increased by 67 percent in the last two years. China and Korea witnessed a growth of 120 percent and 155 percent respectively, in the last couple of years. Thailand and Singapore witnessed a growth of over 60 percent in a number of studies. While, Taiwan has the largest active ongoing clinical trial studies with over 822 trials India and Indonesia are growing at over 50 percent. There is no change in the number of trial studies in Hong Kong. But the scene is different in Vietnam, as the country witnessed a drop of 15 percent in the number of clinical trial studies.

With the support of the local government, rise in spending on setting up healthcare infrastructure, lower cost of conducting clinical studies and encouraging regulatory framework, the region is witnessing an increase in the number of clinical research organizations (CROs) in the last few years. Along with the partnerships/alliance between CROs of different countries, this trend will continue in the coming years too.